SC
OLMA icon

Steven Cohen’s Olema Pharmaceuticals OLMA Stock Holding History

Steven Cohen’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5K Buy
+2,200
New +$29.5K ﹤0.01% 3853

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Steven Cohen's OLMA Position: Q2 2026 in Review

Steven Cohen increased its Olema Pharmaceuticals (OLMA) stake by 1,406% in Q2 2026, buying an estimated $13.4M and bringing the position to 1,070,949 shares worth $13.4M. The position accounts for 0.01% of the portfolio, ranked #1106.

Steven Cohen first reported a position in OLMA in Q1 2021 and has held it in 10 quarters since. The position peaked at $44M in Q3 2024. 182 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Steven Cohen held 1,070,949 shares of Olema Pharmaceuticals worth $13.4M as of Q2 2026.
  • Steven Cohen bought 999,842 Olema Pharmaceuticals shares in Q2 2026, an estimated $13.4M.
  • Olema Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1106 holding.
  • Steven Cohen first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 10 quarters since.
  • Steven Cohen's Olema Pharmaceuticals position peaked at $44M in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.